Silphium Asset Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History
Bought
Maintained
Sold
Silphium Asset Management's IMGO Position: Q1 2023 in Review
Silphium Asset Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 50,000 shares — an estimated $1.8M sold.
Silphium Asset Management first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $1.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.
- Silphium Asset Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
- Silphium Asset Management sold 50,000 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $1.8M.
- Silphium Asset Management first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
- Silphium Asset Management's Imago BioSciences, Inc. Common stock position peaked at $1.8M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.
Based on Silphium Asset Management's 13F filing for Q1 2023, filed 30 Jan 2025.